HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Direct-acting antiviral (DAA) combinations are potent and effective drugs currently recommended for treatment of chronic HCV infection. Difficult to treat genotypes are the most important predictors of treatment failure. We report a case of DAA treatment failure in an HCV-infected patient carrying a recombinant genotype 2k/1b. This strain, first isolated from a Russian patient in 2002, has now been observed for the first time in Italy.

Original languageEnglish
Pages (from-to)365-368
Number of pages4
JournalAntiviral Therapy
Volume22
Issue number4
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Treatment Failure
Italy
Antiviral Agents
Genotype
Infection
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy. / Paolucci, Stefania; Premoli, Marta; Ludovisi, Serena; Mondelli, Mario U.; Baldanti, Fausto.

In: Antiviral Therapy, Vol. 22, No. 4, 01.01.2017, p. 365-368.

Research output: Contribution to journalArticle

@article{b58d335f28bb4917bba8af74e573bcb3,
title = "HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy",
abstract = "Direct-acting antiviral (DAA) combinations are potent and effective drugs currently recommended for treatment of chronic HCV infection. Difficult to treat genotypes are the most important predictors of treatment failure. We report a case of DAA treatment failure in an HCV-infected patient carrying a recombinant genotype 2k/1b. This strain, first isolated from a Russian patient in 2002, has now been observed for the first time in Italy.",
author = "Stefania Paolucci and Marta Premoli and Serena Ludovisi and Mondelli, {Mario U.} and Fausto Baldanti",
year = "2017",
month = "1",
day = "1",
doi = "10.3851/IMP3130",
language = "English",
volume = "22",
pages = "365--368",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "4",

}

TY - JOUR

T1 - HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy

AU - Paolucci, Stefania

AU - Premoli, Marta

AU - Ludovisi, Serena

AU - Mondelli, Mario U.

AU - Baldanti, Fausto

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Direct-acting antiviral (DAA) combinations are potent and effective drugs currently recommended for treatment of chronic HCV infection. Difficult to treat genotypes are the most important predictors of treatment failure. We report a case of DAA treatment failure in an HCV-infected patient carrying a recombinant genotype 2k/1b. This strain, first isolated from a Russian patient in 2002, has now been observed for the first time in Italy.

AB - Direct-acting antiviral (DAA) combinations are potent and effective drugs currently recommended for treatment of chronic HCV infection. Difficult to treat genotypes are the most important predictors of treatment failure. We report a case of DAA treatment failure in an HCV-infected patient carrying a recombinant genotype 2k/1b. This strain, first isolated from a Russian patient in 2002, has now been observed for the first time in Italy.

UR - http://www.scopus.com/inward/record.url?scp=85025708368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025708368&partnerID=8YFLogxK

U2 - 10.3851/IMP3130

DO - 10.3851/IMP3130

M3 - Article

AN - SCOPUS:85025708368

VL - 22

SP - 365

EP - 368

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 4

ER -